| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 02/22/2011 | CA2474823C Heteroaryl substituted 2-pyridinyl and 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a] pyrimidin-4-one derivatives |
| 02/22/2011 | CA2463968C Anthranilic acid amides and their use as vegf receptor tyrosine kinase inhibitors |
| 02/22/2011 | CA2328438C Heterocyclically substituted amides, their production and their use |
| 02/17/2011 | WO2011019940A2 Deuterated water and riboflavin solution for extending singlet oxygen lifetimes in treatment of ocular tissue and method for use |
| 02/17/2011 | WO2011019679A1 Ccr2 inhibitors for treating conditions of the eye |
| 02/17/2011 | WO2011019678A1 Isothiozoles for treating conditions of the eye |
| 02/17/2011 | WO2011019410A1 Ophthalmic drug delivery system containing phospholipid and cholesterol |
| 02/17/2011 | WO2011019081A1 Light-receiving channel rhodopsin having improved expression efficiency |
| 02/17/2011 | WO2011018588A2 Fgf receptor-activating n-acyl octasaccharides, preparation thereof, and therapeutic use thereof |
| 02/17/2011 | WO2011018587A2 Fgf receptor-activating n-sulfate oligosaccharides, preparation thereof, and therapeutic use thereof |
| 02/17/2011 | US20110040240 Methods for treating rhinitis and conjunctivitis |
| 02/17/2011 | US20110040161 Device for generating a detectable signal based upon concentration of at least one substance |
| 02/17/2011 | US20110039919 Pharmaceutical compositions for inhibiting angiogenesis |
| 02/17/2011 | US20110039916 Helper Virus-Free Herpesvirus Amplicon Particles and Uses Thereof |
| 02/17/2011 | US20110039900 Isothiozoles for treating conditions of the eye |
| 02/17/2011 | US20110039891 Methods for treating a disease in which Rho kinase is involved |
| 02/17/2011 | US20110039866 Selective sphingosine-1-phosphate receptor antagonists |
| 02/17/2011 | US20110039864 Therapeutic compounds |
| 02/17/2011 | US20110039861 Cyclic azaindole-3-carboxamides, their preparation and their use as pharmaceuticals |
| 02/17/2011 | US20110039835 Substituted arylamide diazepinopyrimidone derivatives |
| 02/17/2011 | US20110039830 Cyclic indole-3-carboxamides, their preparation and their use as pharmaceuticals |
| 02/17/2011 | US20110039805 Method for treating meibomian gland disease |
| 02/17/2011 | US20110039790 Enhanced ocular neuroprotection and neurostimulation |
| 02/17/2011 | US20110038937 Methods for delivering siRNA via Ionthophoresis |
| 02/17/2011 | US20110038913 Polymeric endoprostheses with modified erosion rates and methods of manufacture |
| 02/17/2011 | US20110038896 Biodegradable immunomodulatory formulations and methods for use thereof |
| 02/17/2011 | US20110038871 Ccr2 inhibitors for treating conditions of the eye |
| 02/17/2011 | US20110038832 Method for treatment of macular degeneration using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione |
| 02/17/2011 | CA2771056A1 Fgf receptor-activating n-acyl octasaccharides, preparation thereof, and therapeutic use thereof |
| 02/17/2011 | CA2771055A1 Fgf receptor-activating n-sulfate oligosaccharides, preparation thereof, and therapeutic use thereof |
| 02/17/2011 | CA2770894A1 Isothiozoles for treating conditions of the eye |
| 02/17/2011 | CA2769929A1 Ophthalmic drug delivery system containing phospholipid and cholesterol |
| 02/16/2011 | EP2284189A2 Nucleic acid molecules encoding fibroblast growth factor-like (FGF-like) polypeptides |
| 02/16/2011 | EP2283869A2 Selected antibodies and duramycin peptides binding to anionic phospholipids and aminophospholipids and their use in the treatment of viral infections and cancer |
| 02/16/2011 | EP2283868A2 Selected antibodies and duramycin peptides binding to anionic phospholipids and aminophospholipids and their use in the treatment of viral infections and cancer |
| 02/16/2011 | EP2283865A1 Method of increasing testosterone and related steroid concentrations in women |
| 02/16/2011 | EP2283863A1 Model and method for angiogenesis inhibition |
| 02/16/2011 | EP2283845A1 Sustained release drug delivery system containing codrugs |
| 02/16/2011 | EP2283835A2 Method and preparation for treating metabolic stress |
| 02/16/2011 | EP2283041A1 Humanized anti-factor d antibodies and uses thereof |
| 02/16/2011 | EP1469077B1 Cell-specific expression/replication vector |
| 02/16/2011 | EP1455794B1 ClC-2 CHANNEL OPENER FOR TREATING GASTRIC OR BOWEL ULCER |
| 02/16/2011 | CN1846456B Communication system for wireless microphone |
| 02/16/2011 | CN101977931A Polypeptide and pharmaceutical composition containing the polypeptide |
| 02/16/2011 | CN101977604A Fluoroquinolone derivatives for ophthalmic applications |
| 02/16/2011 | CN101977599A Composition of aqueous buffer solution for the treatment of cellular environment and ion channels and methods for using same |
| 02/16/2011 | CN101977595A Compositions for the treatment and prevention of eyelid swelling |
| 02/16/2011 | CN101974068A Tanshinon IIA crylic acid or sodium salt thereof, preparation method and application thereof |
| 02/16/2011 | CN101973998A Pyrrolopyrimidine A2b selective antagonist compounds, their synthesis and use |
| 02/16/2011 | CN101972483A RNAI-mediated inhibition of spleen tyrosine kinase-related inflammatory conditions |
| 02/16/2011 | CN101972470A In-situ gel composition for eyes |
| 02/16/2011 | CN101972427A Traditional Chinese medicine for treating chronic glaucoma |
| 02/16/2011 | CN101972343A Traditional Chinese medicine for treating diabetic oculopathy |
| 02/16/2011 | CN101972341A Soup with function of promoting restoration of consciousness and hearing |
| 02/16/2011 | CN101972340A Traditional Chinese medicine composition for tonifying liver and improving eyesight |
| 02/16/2011 | CN101972241A Application of composition containing 2-(3,4-dihydroxyphenyl) ethanol or glycoside thereof in preparing skin-whitening composition |
| 02/16/2011 | CN101972224A Eye in-situ gel |
| 02/16/2011 | CN101518483B Biological vision assisting system |
| 02/16/2011 | CN101385769B Blueberry pearl chewing tablet and preparation method thereof |
| 02/16/2011 | CN101269156B Chinese medicinal composition for treating eye disease |
| 02/15/2011 | US7888389 Tetrapropylammonium tetrathiomolybdate and related compounds for anti-angiogenic therapies |
| 02/15/2011 | US7888348 7-membered ring compound and method of production and pharmaceutical application thereof |
| 02/15/2011 | US7888336 Indole compounds bearing aryl or heteroaryl groups having sphingosine 1-phosphate (S1P) receptor biological activity |
| 02/15/2011 | US7887823 Oat extracts: refining, compositions and methods of use |
| 02/15/2011 | US7887799 Antibodies to fibroblast growth factor-like polypeptides |
| 02/15/2011 | US7887795 processing adipose tissue to deliver a concentrated amount of stem cells obtained from the adipose tissue to a patient; making an enhanced, autologous fat graft comprising supplementing a first portion of extracted adipose tissue with an additive and a disaggregated population of adipose-derived cells |
| 02/15/2011 | CA2558272C Pyridone derivative |
| 02/15/2011 | CA2480872C Amino acids with affinity for the .alpha.-2-.delta.-protein |
| 02/15/2011 | CA2478156C Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 02/15/2011 | CA2470067C Imidazoquinoline derivatives |
| 02/15/2011 | CA2452502C 2-(3,5-bis-trifluoromethyl-phenyl)-n-[6-(1,1-dioxo-1.lambda.6-thiomorpholin-4-yl)-4-(2-methyl or 4-fluoro-2-methyl substituted)phenyl-pyridin-3-yl]-n-methyl-isobutyramide |
| 02/15/2011 | CA2452445C Modulators of cellular proliferation and angiogenesis, methods for use and identification thereof |
| 02/15/2011 | CA2286397C Humanized antibodies and methods for forming humanized antibodies |
| 02/10/2011 | WO2011017313A1 Method of administering non-viral nucleic acid vectors to the eye |
| 02/10/2011 | WO2011017178A1 Compositions and methods for inhibition of the jak pathway |
| 02/10/2011 | WO2011016562A1 Ophthalmic composition for silicone hydrogel contact lens |
| 02/10/2011 | WO2011016459A1 Thienooxazepine derivative |
| 02/10/2011 | US20110034558 DP2 Antagonist and Uses Thereof |
| 02/10/2011 | US20110034554 Compositions and methods for treating macular degeneration |
| 02/10/2011 | US20110034547 Chondropsin-class antitumor v-atpase inhibitor compounds, compositions and methods of use thereof |
| 02/10/2011 | US20110034546 Methods to produce rod-derived cone viability factor (rdcvf) |
| 02/10/2011 | US20110034534 siRNA compounds and methods of use thereof |
| 02/10/2011 | US20110034527 Novel 2-amino benzimidazole derivatives and their use as modulators of small-conductance calcium-activated potassium channels |
| 02/10/2011 | US20110034497 Indazole inhibitors of the wnt signal pathway and therapeutic uses thereof |
| 02/10/2011 | US20110034485 Nitrone compounds, process of preparation thereof, and use thereof in medicament manufacture |
| 02/10/2011 | US20110034472 Novel Compounds for Treatment of Cancer and Disorders Associated With Angiogenesis Function |
| 02/10/2011 | US20110034448 Carbonic anhydrase inhibitor sustained release intraocular drug delivery systems |
| 02/10/2011 | US20110034441 Indazoles as wnt/b-catenin signaling pathway inhibitors and therapeutic uses thereof |
| 02/10/2011 | US20110034430 Phospholipid Gel Compositions for Drug Delivery and Methods of Treating Conditions Using Same |
| 02/10/2011 | US20110034422 Dendrimers for sustained release of compounds |
| 02/10/2011 | US20110034414 Fluoroalkyloxy alkanes, process for production and uses thereof |
| 02/10/2011 | US20110034387 Polypeptide inhibiting angiogenesis and application thereof |
| 02/10/2011 | US20110033527 Opthalmic compositions of cyclosporin |
| 02/10/2011 | US20110033468 Ophthalmic Drug Delivery System Containing Phospholipid and Cholesterol |
| 02/10/2011 | CA2768543A1 Compositions and methods for inhibition of the jak pathway |
| 02/09/2011 | EP2281891A2 Streptococcus antigens |
| 02/09/2011 | EP2281828A2 Compositions comprising modified erythropoietin |
| 02/09/2011 | EP2281818A1 Fused pyridazine derivative compounds and drugs containing these compounds as the active ingredient |
| 02/09/2011 | EP2281578A2 Selected antibodies and duramycin peptides binding to anionic phospholipids and aminophospholipids and their use in treating viral infections and cancer |
| 02/09/2011 | EP2281568A2 Uses of soluble CTLA4 mutant molecules |